Inborn errors of immunity: a structured model for paediatric-to-adult transition of care - Report - MDSpire

Inborn errors of immunity: a structured model for paediatric-to-adult transition of care

  • By

  • Adele Civino

  • Federico Diomeda

  • Concetta D’Orio

  • Stefania Antonacci

  • Giulia Loiacono

  • Angelo Vacca

  • Baldassarre Martire

  • May 11, 2026

  • 0 min

Share

Clinical Report: Transitioning Care from Pediatric to Adult Services in IEI

Overview

This report outlines a structured framework for transitioning care from pediatric to adult services for patients with inborn errors of immunity (IEI). The proposed model emphasizes early identification, multidisciplinary engagement, and comprehensive documentation to enhance treatment adherence and care continuity.

Background

The transition from pediatric to adult healthcare is a critical phase for patients with inborn errors of immunity (IEI), which are characterized by persistent immune dysfunction and significant morbidity. As advancements in diagnostics and therapies allow more individuals with IEI to reach adulthood, the need for effective transition protocols becomes increasingly important. Poor transition practices can lead to medical complications, treatment non-compliance, and adverse long-term outcomes.

Data Highlights

No numerical data provided in the article.

Key Findings

  • A structured, multidisciplinary transition protocol is essential for patients with IEI.
  • Transition should begin around age 14, with a minimum overlap period of three years between pediatric and adult care.
  • Comprehensive documentation, including a standardized clinical dossier and transition report, is crucial for seamless care.
  • Monitoring quantifiable indicators such as infection rates and patient-reported quality of life is recommended.
  • Immunoglobulin replacement therapy options should be tailored to individual patient needs and developmental stages.

Clinical Implications

Healthcare providers should adopt a standardized approach to transition care for patients with IEI, ensuring early identification and multidisciplinary collaboration. Regular evaluations and documentation of patient progress can enhance adherence to treatment and improve long-term health outcomes.

Conclusion

Implementing a structured transition framework for patients with IEI can significantly reduce care discontinuity and improve disease management as patients move into adulthood. Future research is needed to validate the effectiveness of this model.

Related Resources & Content

  1. Clinical Rheumatology, 2025 -- Outcomes of Transitioning from Pediatric to Adult Care in Patients with Juvenile Idiopathic Arthritis
  2. Clinical Rheumatology, 2015 -- Current Landscape and Obstacles in Transitional Care for Young Individuals with Juvenile Idiopathic Arthritis within Clinical Networks
  3. Handing off hope: transition of care in pediatric surgery, 2025
  4. Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care | Journal of Clinical Immunology
  5. Inborn errors of immunity: manifestation, treatment, and outcome – an ESID registry 1994–2024 report on 30,628 patients
  6. Infection — UniteID: A Framework for Developing Pediatric Infectious Disease Specialists Through Adult Infectious Disease Programs
  7. Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care | Journal of Clinical Immunology | Springer Nature Link
  8. Inborn errors of immunity: manifestation, treatment, and outcome – an ESID registry 1994–2024 report on 30,628 patients - PMC
  9. Immunoglobulin replacement therapy for primary immunodeficiencies

Original Source(s)

Related Content